Please assess the completion status of the following clinical trial:

Trial Title: Surveillance Study of Patients With Newly Diagnosed Osteosarcoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria~Each patient must meet all of the following inclusion criteria to be enrolled in the study:~* Male or female aged 2 to 40 years~* Confirmed pathological diagnosis of newly-diagnosed, nonmetastatic, resectable, primary, high-grade osteosarcoma~* Have completed definitive surgery (or other local ablation technique)~* Have a treatment regimen that includes mifamurtide and a minimum of 2 recognized chemotherapy agents in the treatment of osteosarcoma (cisplatin, doxorubicin, high-dose methotrexate or ifosfamide)~* Organ function deemed satisfactory to receive planned chemotherapy containing at minimum 2 of the recognized chemotherapy agents in the treatment of osteosarcoma~* Voluntary Written Consent~Exclusion Criteria~Patients meeting any of the following exclusion criteria are not to be enrolled in the study:~* Female patients who are lactating and breastfeeding or have a positive serum pregnancy test during the screening period~* History of pericarditis or pleuritis~* Have low-grade osteosarcoma or parosteal or periosteal sarcoma~* Have osteosarcoma associated with Paget's disease~* Current treatment with any anticancer investigational products at the time of enrollment in this study

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- High-grade osteosarcoma patients (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).